Gout Clinical Research Study

About This Study

This clinical research study is evaluating an investigational treatment for adults with gout who have not achieved adequate control with current therapies. The study medication aims to lower uric acid levels more effectively, potentially reducing the frequency and severity of gout flares.

What is Gout?

Gout is a form of inflammatory arthritis caused by the buildup of uric acid crystals in the joints. It typically causes sudden, severe attacks of pain, swelling, and redness—often affecting the big toe first. Without proper management, gout can lead to chronic joint damage and significantly impact quality of life.

Learn more about gout at Overlake Arthritis →

Who May Qualify

You may be eligible for this study if you:

• Are 18 years of age or older
• Have been diagnosed with gout
• Have experienced gout flares in the past year
• Have elevated uric acid levels despite current treatment
• Are willing to attend all scheduled study visits

Additional eligibility criteria will be reviewed during the screening process. Use the questionnaire below to get a preliminary assessment.

What Participation Involves

If you qualify and choose to participate, the study typically includes:

• Screening Visit: Medical history review, physical exam, blood tests
• Treatment Period: Approximately 12-24 weeks of study medication
• Study Visits: Regular visits every 4-6 weeks for monitoring
• Follow-up: A final visit after completing treatment

Compensation

Qualified participants may receive:

• Study-related medical care at no cost
• Study medication at no cost
• Compensation for time and travel (amount varies by study)

Your Safety

Your safety is our top priority. All clinical trials are:

• Reviewed and approved by an Independent Ethics Committee (IRB)
• Conducted according to FDA regulations and Good Clinical Practice guidelines
• Monitored continuously for safety
• Voluntary—you may withdraw at any time